ANALYSIS OF THE WORK OF A MULTIDISCIPLINARY GROUP IN THE TREATMENT OF LUNG CANCER IN THE TURKESTAN REGION FOR 2019-2020
Introduction: The introduction of a multidisciplinary approach to the treatment of lung cancer has now become very much in demand, since the precise determination of the molecular and biological characteristics of the tumor, before the start of treatment, allows for a significant improvement in the results of increasing overall and relapse-free survival.
The aim of the study is to analyze the performance of a multidisciplinary group in the treatment of lung cancer and to study mutations in the EGFR, ALK gene in the Turkestan region for 2019-2020.
Materials and methods: The study is a retrospective observational one. An analysis was made of the performance indicators of a multidisciplinary group working on the basis of the oncological center of the Turkestan region for 2019-2020.During the study period, 391 patients were examined by a multidisciplinary group. The analyzed indicators were: patient's age, gender, histological data, diagnosis, stages, types of treatment.
All statistical calculations were performed using the SPSS program (version 25.0, IBM SPSS Inc., Chicago, USA).The data were summarized using descriptive statistics methods.
Statistical processing of the obtained data was carried out using Microsoft Excel, the average value was determined. The data were summarized using descriptive statistics methods.
Results: The largest number of patients with lung cancer were referred for combined treatment, palliative chemotherapy, targeted therapy. In 2020, compared to 2019, the percentage of combination therapy increased by 3%, and the percentage of targeted therapy increased by 4%. Mutations of the EGFR gene were detected, of which Ex19del, L858R, Ex20Ins, T790M were detected.
Conclusion: For the first time, an analysis of the work of MDG in the treatment of lung cancer in the Turkestan region for 2019-2020 was carried out. Improved diagnostics of indicators of molecular genetic studies in the EGFR gene, ALK-positive metastatic non-small cell lung cancer, which made it possible to optimize the choice of personalized treatment tactics for patients and refer them to combined treatment, palliative chemotherapy and targeted therapy, which reduced the number of registrations of new cases of advanced lung cancer.
Number of Views: 95
Category of articles:
Original articles
Bibliography link
Tumenbayeva Zh.S. Analysis of the work of a multidisciplinary group in the treatment of lung cancer in the Turkestan region for 2019-2020 // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 3, pp. 101-107. doi 10.34689/SH.2023.25.3.013Related publications:
A COMPARATIVE ANALYSIS OF 24-HOUR DIETARY RECALLS AND FOOD FREQUENCY QUESTIONNAIRES ADMINISTERED SIMULTANEOUSLY IN THE KAZAKHSTANI POPULATION
ANALYSIS OF PATIENT SATISFACTION WITH THE QUALITY OF ORGANIZATION OF TREATMENT IN FOREIGN CLINICS
CLINICAL AND LABORATORY PREDICTORS OF THE SEVERITY OF COVID-19 INFECTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
POST-MARKETING STUDY OF THE CLINICAL EFFICACY AND SAFETY OF GRIPMAX NOS IN THE TREATMENT OF ACUTE RESPIRATORY INFECTIONS OF THE UPPER RESPIRATORY TRACT
EXPERIENCE IN IMPROVING SURGICAL TREATMENT WHEN IMPOSING A STOMA IN CHILDREN WITH HIRSPRUNG'S DISEASE